The Global Lyophilized Injectable Drugs Market Size accounted for USD 2.9 Billion in 2021 and is projected to occupy a market size of USD 5.1 Billion by 2030 growing at a CAGR of 6.5% from 2022 to 2030.
Lyophilization is a water removal process used to preserve perishable items. This process is used in manufacturing or parenteral, where the solution has little or no stability. This procedure is completed in four steps. They are freezing, secondary dying, primary dying, and packaging in the conainer. The lyophilized injectable drugs market is expected to grow at a rapid pace owing to the increase in development of pipeline of lyophilized injectable drugs.
Lyophilized Injectable Drugs Market Report Statistics
- Global lyophilized injectable drugs market revenue is projected to reach USD 5.1 Billion by 2030 with a CAGR of 6.5% from 2022 to 2030
- North America lyophilized injectable drugs market share generated over 47% shares in 2021
- Asia-Pacific lyophilized injectable drugs market growth will register impressive CAGR of over 7% from 2022 to 2030
- Based on packaging type, single-use vials recorded over 60% of the overall market share in 2021
- Among type of delivery, prefilled diluent syringes generated shares of over 53% in 2021
- Growth in contract manufacturing services is a popular lyophilized injectable drugs market trend that fuels the industry demand
Global Lyophilized Injectable Drugs Market Dynamics
Market Drivers
- Increasing awareness for healthy life
- Rise in medical conditions such as metabolic and cardiac disorders
- Surge in respiratory disorders
- Extension of pipeline of lyophilized injectable drugs
Market Restraints
- Growing number of product recalls
- Presence of glass particles in the product
Market Opportunities
- Expanding healthcare infrastructure
- Growing number of contract manufacturing and research services
Lyophilized Injectable Drugs Market Report Coverage
| Market |
Lyophilized Injectable Drugs Market |
| Lyophilized Injectable Drugs Market Size 2021 |
USD 2.9 Billion |
| Lyophilized Injectable Drugs Market Forecast 2030 |
USD 5.1 Billion |
| Lyophilized Injectable Drugs Market CAGR During 2022 - 2030 |
6.5% |
| Lyophilized Injectable Drugs Market Analysis Period |
2018 - 2030 |
| Lyophilized Injectable Drugs Market Base Year |
2021 |
| Lyophilized Injectable Drugs Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Packaging Type, By Type of Delivery, By Indication, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Schott AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, Novartis AG, SHL Group, B. Braun Melsungen AG, and Jubilant HollisterStier.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Lyophilized Injectable Drugs Market Growth Factors
Growing health awareness and rise in demand for lyophilized injectable drugs in various medical conditions such as metabolic and cardiac diseases are the major driving factors that are boosting the growth of the lyophilized injectable drugs market. Also, governments stringent regulation and low emission policies across the globe encourage the usage of lyophilized injectable drugs that integrates low rolling resistant tires and aerodynamics that helps in fuel savings as well as reduce carbon emissions which are the key factors driving the growth of the global lyophilized injectable drugs market.
Lyophilized Injectable Drugs Market Insights
The lyophilized injectable drugs are costly in terms of manufacturing process; therefore, the key manufacturers in the global market are investing on R&D activities to offer a substitute method that will help to extend the product’s shelf life. Though, this substitute method requires development related to absorbent stability and biological activity of the material. For instance, for instance, in September 2015, Purdue University has introduced lyophilization association named LyoHUB with an objective to develop advanced freeze-drying technology to make it safer and more affordable for pharmaceuticals and biotech products.
Lyophilized Injectable Drugs Market Segmentation
The global lyophilized injectable drugs market is segmented based on packaging type, type of delivery, indication, end-user, and geography.
Lyophilized Injectable Drugs Market By Packaging Type
- Specialty Packaging
- Point-Of-Care Reconstitution
- Single-Use Vials
- Others
Based on packaging type, the global lyophilized injectable drugs market ismajorly segmented into three sub-segments, which arespecialty packaging, point-of-care reconstitution, single-use vials. The specialty packaging segment is predicted to lead the global lyophilized injectable drugs market owing to the wide spread of lyophilized injectable drugs in several chronic diseases.
Lyophilized Injectable Drugs Market By Type of Delivery
- Single-Step Devices
- Multi-Step Devices
- Prefilled Diluent Syringes
- Proprietary Reconstitution Devices
According to the lyophilized injectable drugs industry analysis, prefilled diluent syringes accounted for the largest market share in 2021 and is expected to continue its trend during the forecast timeframe. A prefilled syringe is a single-dose vaccine container with a needle made by the manufacturer. These syringes are used to collect injectable medications and diluents.
Lyophilized Injectable Drugs Market By Indication
- Infectious Diseases
- Autoimmune Diseases
- Metabolic Conditions
- Others
According to the lyophilized injectable drugs market forecast, metabolic diseases are expected to hold a significant market share between 2022 and 2030. The factors that can be attributed to the increasing demand for lyophilized drugs in a variety of medical conditions, such as metabolic and cardiac diseases, are fueling demand for this segment. On the other hand, infectious diseases sub-segment is anticipated to witness significant growth rate in the coming years.
Lyophilized Injectable Drugs Market By End-User
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Specialty Clinics
- Others
Based on end-user segment, hospitals sub-segment gathered considerable amount of share in 2021. The presence of advanced medical equipment, presence of healthcare professionals, and increasing investment in healthcare infrastructure are some of the factors that are driving the hospitals segment. However, specialty clinics sub-segment is likely to attain substantial growth rate from 2022 to 2030. The factors that can be credited to the ease of reconstitution, particularly for vaccines and injectables that need to be administered quickly increase the demand for this segment.
Lyophilized Injectable Drugs Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Lyophilized Injectable Drugs Market Regional Analysis
The North America region is predicted to dominate the lyophilized injectable drugs market owing to technological advancement and huge investment by manufacturers in research and development in this region. Also, due to the huge presence of contract manufacturing and services is expected to drive the lyophilized injectable drugs market in North America region.
Asia-Pacific is projected to grow at high CAGR and expected to create growth opportunities for manufacturers as there is increase in healthcare spending in developing countries. Countries such as Singapore, Malaysia and Thailand are expected to create significant opportunities in the healthcare industry. Moreover, the improved medical infrastructure facilities are likely to boost the demand of the lyophilized injectable drugs market.
Lyophilized Injectable Drugs Market Players
Some of the key vendors operating in the lyophilized injectable drugs market are Schott AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, SHL Group, B. Braun Melsungen AG, Jubilant HollisterStier, and others.
Key vendors are highly focused on investment in research and development activities to manufacture innovative lyophilized injectable drugs using advanced technologies. Furthermore, the manufacturers operating in the global lyophilized injectable drugs market are strategically focused product innovation and partnership, merger and acquisition of other players in healthcare industry in order to increase their product portfolio as well as expand their customer base globally.
CHAPTER 1. Industry Overview of Lyophilized Injectable Drugs Market
1.1. Definition and Scope
1.1.1. Definition of Lyophilized Injectable Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Lyophilized Injectable Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Lyophilized Injectable Drugs Market By Packaging Type
1.2.3. Lyophilized Injectable Drugs Market By Type of Delivery
1.2.4. Lyophilized Injectable Drugs Market By Indication
1.2.5. Lyophilized Injectable Drugs Market By End-User
1.2.6. Lyophilized Injectable Drugs Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Lyophilized Injectable Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Lyophilized Injectable Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Lyophilized Injectable Drugs Market By Packaging Type
4.1. Introduction
4.2. Lyophilized Injectable Drugs Market Revenue By Packaging Type
4.2.1. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast, By Packaging Type, 2018-2030
4.2.2. Specialty Packaging
4.2.2.1. Specialty Packaging Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Point-Of-Care Reconstitution
4.2.3.1. Point-Of-Care Reconstitution Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Single-Use Vials
4.2.4.1. Single-Use Vials Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Others
4.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Lyophilized Injectable Drugs Market By Type of Delivery
5.1. Introduction
5.2. Lyophilized Injectable Drugs Market Revenue By Type of Delivery
5.2.1. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast, By Type of Delivery, 2018-2030
5.2.2. Single-Step Devices
5.2.2.1. Single-Step Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Multi-Step Devices
5.2.3.1. Multi-Step Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Prefilled Diluent Syringes
5.2.4.1. Prefilled Diluent Syringes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Proprietary Reconstitution Devices
5.2.5.1. Proprietary Reconstitution Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Lyophilized Injectable Drugs Market By Indication
6.1. Introduction
6.2. Lyophilized Injectable Drugs Market Revenue By Indication
6.2.1. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast, By Indication, 2018-2030
6.2.2. Infectious Diseases
6.2.2.1. Infectious Diseases Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Autoimmune Diseases
6.2.3.1. Autoimmune Diseases Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Metabolic Diseases
6.2.4.1. Metabolic Diseases Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Lyophilized Injectable Drugs Market By End-User
7.1. Introduction
7.2. Lyophilized Injectable Drugs Market Revenue By End-User
7.2.1. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast, By End-User, 2018-2030
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Ambulatory Surgery Centers (ASCs)
7.2.3.1. Ambulatory Surgery Centers (ASCs) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Specialty Clinics
7.2.4.1. Specialty Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Lyophilized Injectable Drugs Market By Country
8.1. North America Lyophilized Injectable Drugs Market Overview
8.2. U.S.
8.2.1. U.S. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
8.2.2. U.S. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
8.2.3. U.S. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.2.4. U.S. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Canada
8.3.1. Canada Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
8.3.2. Canada Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
8.3.3. Canada Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
8.3.4. Canada Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Lyophilized Injectable Drugs Market By Country
9.1. Europe Lyophilized Injectable Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
9.2.2. U.K. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
9.2.3. U.K. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.2.4. U.K. Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Germany
9.3.1. Germany Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
9.3.2. Germany Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
9.3.3. Germany Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.3.4. Germany Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. France
9.4.1. France Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
9.4.2. France Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
9.4.3. France Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.4.4. France Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Spain
9.5.1. Spain Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
9.5.2. Spain Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
9.5.3. Spain Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.5.4. Spain Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
9.6.2. Rest of Europe Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
9.6.3. Rest of Europe Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
9.6.4. Rest of Europe Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia-Pacific Lyophilized Injectable Drugs Market By Country
10.1. Asia-Pacific Lyophilized Injectable Drugs Market Overview
10.2. China
10.2.1. China Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.2.2. China Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.2.3. China Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.2.4. China Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Japan
10.3.1. Japan Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.3.2. Japan Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.3.3. Japan Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.3.4. Japan Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. India
10.4.1. India Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.4.2. India Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.4.3. India Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.4.4. India Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Australia
10.5.1. Australia Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.5.2. Australia Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.5.3. Australia Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.5.4. Australia Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.6. South Korea
10.6.1. South Korea Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.6.2. South Korea Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.6.3. South Korea Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.6.4. South Korea Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
10.7.2. Rest of Asia-Pacific Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
10.7.3. Rest of Asia-Pacific Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
10.7.4. Rest of Asia-Pacific Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.8. Asia-Pacific PEST Analysis
CHAPTER 11. Latin America Lyophilized Injectable Drugs Market By Country
11.1. Latin America Lyophilized Injectable Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
11.2.2. Brazil Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
11.2.3. Brazil Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.2.4. Brazil Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. Mexico
11.3.1. Mexico Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
11.3.2. Mexico Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
11.3.3. Mexico Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.3.4. Mexico Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
11.4.2. Rest of Latin America Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
11.4.3. Rest of Latin America Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
11.4.4. Rest of Latin America Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Lyophilized Injectable Drugs Market By Country
12.1. Middle East & Africa Lyophilized Injectable Drugs Market Overview
12.2. GCC
12.2.1. GCC Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
12.2.2. GCC Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
12.2.3. GCC Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
12.2.4. GCC Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.3. South Africa
12.3.1. South Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
12.3.2. South Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
12.3.3. South Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
12.3.4. South Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Packaging Type, 2018-2030
12.4.2. Rest of Middle East & Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Type of Delivery, 2018-2030
12.4.3. Rest of Middle East & Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By Indication, 2018-2030
12.4.4. Rest of Middle East & Africa Lyophilized Injectable Drugs Market Revenue (USD Billion) and Forecast By End-User, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Lyophilized Injectable Drugs Market
13.1. Lyophilized Injectable Drugs Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Lyophilized Injectable Drugs Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Schott AG
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2021
14.1.3.2. Schott AG 2021 Lyophilized Injectable Drugs Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Novartis AG
14.3. CIRON Drugs & Pharmaceuticals Pvt. Ltd
14.4. Mylan N.V.
14.5. Baxter
14.6. Vetter Pharma
14.7. Dickinson and Company
14.8. SHL Group
14.9. B. Braun Melsungen AG
14.10. Jubilant HollisterStier
